A 65-year-old man presented with blurred vision in the right eye for 2 months. There was a 3-mm mass located at 9:30-o’clock iridocorneal angle with neovascular surface (A, arrow). A few neoplasms appeared on the iris (A, triangle). The patient received intravitreal injection of bevacizumab for recurrent hyphema. One month later, the mass had decreased in size, but more scattered neoplasms…

A 34-year-old man with a 1-year history of repaired temporal paralimbal scleral perforation presented with a well-circumscribed pearl-type inferior iris cyst and residual eyelash (A, arrow) in anterior chamber. Swept-source anterior-segment OCT demonstrated a hyperreflective dome-shaped mass obscuring inferior angle (B). On follow-up, it ruptured spontaneously (C). Ultrasound biomicroscopy…

A 68-year-old woman had progressive left exotropia with restrictive adduction and mild pain for 10 years. She denied previous trauma or surgery. Computed tomography scan showed a 0.5 mm–length high-density lesion (A, arrow) at the attachment of the thickening lateral rectus muscle (A and B, ellipse), leading to a focal eminence of the retina (C, arrow). Surgical removal of the high-density lesion…

To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction (MGD).

To investigate whether rates of standard automated perimetry (SAP) mean deviation (MD) over an initial 2-year follow-up period were predictive of events of visual field progression over an extended follow-up.